CHIMERGEN
Pharmaceutical preparations for targeted protein degradation, comprising small molecules, peptides, biologics, antibodies designed for the treatment of cancer, autoimmune diseases, inflammatory conditions, central nervous system (CNS) disorders, and other human diseases; pharmaceutical preparations for degrading disease-causing and pathogenic proteins via lysosomal targeting, ubiquitin-proteasome pathways, or other cellular degradation mechanisms; therapeutic agents for the prevention and tre...
Pending · January 11, 2025 · 98952599 ·